DOCTORGLASSES CHAIN CO.(SZ:300622) Huan Qiu Wang·2026-01-24 01:24Core Viewpoint - The China Securities Regulatory Commission (CSRC) has issued its first fine of 2026, targeting individual Yuhan for manipulating the stock of "Doctor Glasses" through extensive trading activities across 67 accounts over a period of 1252 trading days [1][3]. Group 1: Manipulation Details - Yuhan controlled 67 accounts to manipulate "Doctor Glasses," with buying volume consistently accounting for over 10% of the market volume for an extended period, and exceeding 20% on more than 180 trading days [1][3]. - During the manipulation period, there were 212 trading days where transactions occurred between Yuhan's accounts, with 12 days where the trading volume exceeded 10% of the market volume, peaking at 25.32% [3]. Group 2: Financial Penalties - The CSRC has calculated Yuhan's illegal gains from the manipulation to be 510 million yuan, leading to a total penalty of 1.02 billion yuan, which includes the confiscation of illegal gains and an equal fine [3]. - In addition to the financial penalties, Yuhan has been banned from the securities market for three years, which includes restrictions on trading activities [3]. Group 3: Regulatory Environment - The issuance of this fine is part of a broader regulatory crackdown, with 14 fines already issued in the current year, affecting 11 brokerage firms including Huatai Securities and Zheshang Securities, and resulting in legal accountability for 9 responsible individuals [3]. - The regulatory focus has highlighted issues in various key business areas, including IPO sponsorship, margin financing, ongoing supervision, and illegal trading practices [3].